We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current INDP market cap is 17.25M. The company's latest EPS is USD -1.8062 and P/E is -5.33.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -3.55M | -4.09M | -4.46M | -3.5M | -4.25M |
| Net Income | -3.47M | -3.66M | -4.25M | -3.25M | -3.92M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 1.5M | 0 | 0 | 0 | 0 |
| Operating Income | -43.01M | -3.6M | -7.73M | -14.91M | -16.38M |
| Net Income | -47.6M | -3.58M | -7.71M | -14.32M | -15.42M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 30.45M | 28.06M | 23.15M | 20.85M | 17.79M |
| Total Liabilities | 2.89M | 3.43M | 1.96M | 2.22M | 2.46M |
| Total Equity | 27.57M | 24.63M | 21.19M | 18.63M | 15.33M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 21.28M | 1.78M | 40.58M | 28.06M | 14.92M |
| Total Liabilities | 9.75M | 2.02M | 4.68M | 3.43M | 2.85M |
| Total Equity | 11.54M | -238k | 35.9M | 24.63M | 12.08M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -10.87M | -13.08M | -4.96M | -7.07M | -10.8M |
| Investing | -21.55M | -16.43M | 2.14M | 10.14M | 17.14M |
| Financing | N/A | N/A | N/A | N/A | N/A |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -29.05M | -3.33M | -11.29M | -13.08M | -13.41M |
| Investing | -3.21M | N/A | 448k | -16.43M | 17.14M |
| Financing | 2.37M | 1.16M | 48.34M | N/A | N/A |
| Market Cap | 17.25M |
| Price to Earnings Ratio | -5.33 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 6.15 |
| Price to Book Ratio | 6.81 |
| Dividend Yield | - |
| Shares Outstanding | 8.54M |
| Average Volume (1 week) | 10.71k |
| Average Volume (1 Month) | 24.29k |
| 52 Week Change | -22.90% |
| 52 Week High | 4.08 |
| 52 Week Low | 1.56 |
| Spread (Intraday) | 0.22 (10.38%) |
| Company Name | Indaptus Therapeutics Inc |
| Address |
1007 north orange street wilmington, delaware 19801 |
| Website | https:// |
| Industry | medicinal chems,botanicl pds (2833) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
